CoChat

Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Purpose To administer recombinant erythropoietin to patients with rheumatoid arthritis who had significant anemia, while monitoring hematologic and rheumatologic clinical responses as well as potential toxicity.Patients and methods Seventeen patients with rheumatoid arthritis from five rheumatology care settings were studied. The patients had initial hematocrits of 34% or less and stable clinical status, and were not being treated with second-line drugs or corticosteroids. An 8-week randomized double-blind study involving various dosages of recombinant erythropoietin, as well as placebo, was followed by a 24-week open-label study in which dosage could be titrated to achieve a normal hematocrit.Results In the 8-week randomized study, four of 13 patients who received injections of recombinant erythropoietin showed a hematologic response, arbitrarily defined as at least a 6-unit increase in hematocrit. None of four placebo-treated patients showed a meaningful hematologic response. All 11 patients who completed the subsequent 24-week open-label study reached a normal hematocrit level at some time during the study, and 10 of 11 showed an increase of hematocrit 6 units or greater. At least one adjustment, i.e., an increase, decrease, or omission of the erythropoietin dosage, was required in all patients to maintain the hematocrit at a target range of 35% for women or 40% for men. Meaningful changes were not seen in patients' capacity to perform activities of daily living or pain levels during either the 8-week randomized study or the 24-week open-label study. No adverse effects were associated with recombinant erythropoietin therapy.Conclusion Patients with rheumatoid arthritis showed excellent hematologic responses to recombinant erythropoietin, without toxicity, during careful monitoring for appropriate dosage adjustment, although a meaningful change in rheumatologic clinical status was not seen.

Overview

Integrity signals

Registry

Crossref · 10.1016/0002-9343(90)90294-n

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. Lafyatis, 1988, Demonstration of local production of PDGF and TGF/β by synovial tissue from patients with rheumatoid arthritis, Arthritis Rheum, 31, S62

Cited by

See all 226

Metadata

Authors
Pincus, T., Olsen, N. J., Russell, I. J., Wolfe, F., Robert Harris, E., Schnitzer, T. J., Boccagno, J. A., & Krantz, S. B.
Affiliations
  • Vanderbilt University (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Kansas (US)
  • Rush University Medical Center (US)
Corresponding author
Pincus, Theodore
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
1990-08
Volume
89
Issue
2
Pages
161-168
ISSN
0002-9343 (ISSN-L)
OpenAlex
W1969576864
Cited by
226
References
32
Citations by year
2026: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 4 · 2012: 1
FWCI
13.94
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service (T 32-07186)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-1555)
  • National Center for Research Resources (RR-95)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
recombinant human erythropoietin, rheumatoid arthritis, anemia, hematocrit, dose titration, hematologic response, adverse effects, activities of daily living, pain
MeSH terms
Activities of Daily Living, Adult, Aged, Anemia, Arthritis, Rheumatoid, Double-Blind Method, Erythropoietin, Female, Ferritins, Hematocrit, Humans, Male, Middle Aged, Monitoring, Physiologic, Recombinant Proteins, Multicenter Studies as Topic, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. https://app.cochat.ai/papers/10.1016/0002-9343(90)90294-n
The paper
Pincus, T., Olsen, N. J., Russell, I. J., Wolfe, F., Robert Harris, E., Schnitzer, T. J., Boccagno, J. A., & Krantz, S. B. (1990). Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(90)90294-n

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.